Missing/wrong data?
Log in to edit
Efficacy and safety of the glucagon-like peptide-1 receptor agonist liraglutide added to insulin therapy in poorly regulated patients with type 1 diabetes--a protocol for a randomised, double-blind, placebo-controlled study: the Lira-1 study
scientific article
Author/s
author: Thomas Fremming Dejgaard, Filip K Knop, Lise Tarnow, Jens Juul Holst, Sten Madsbad, Henrik U Andersen, Christian Seerup Frandsen, Tanja Stenbæk Hansen, Thomas Almdal
Work details
Publication date
April 2, 2015
-
-
Language
English
Copyright status
Copyright status information is not available for this work. The copyright status depends on the jurisdiction, the author's date of death and the date the work was created or published.
To learn more about copyright terms in different countries, visit the countries and terms page.